Sovereign-backed transformational technology provider Zenitech to acquire Autsoft Read more

Jess Burgess

Investment Manager

Contact

An Investment Manager at Sovereign, I joined the team to focus on identifying and building opportunities across the Healthcare, Pharmaceutical and UK Technology sectors. My prior experience at Accenture focused on multi-faceted strategic work across a number of regulated industries.

I was inspired by Sovereign's distinctive strategy for growing companies through Buy & Build, their drive to understand each business they engage with and their ability to establish meaningful relationships.

Arriving at Sovereign during the height of the first UK lockdown, there has certainly been no slowdown in our investment activity. Although I have been a part of Sovereign during one of the most active investment years in the past two decades, the role of origination has not changed. Every conversation is as much about understanding business capability as it is about culture and transactability. I value taking the time to work with owner managers until they are ready to commit to a transaction, whether that is imminently or over many years.

This means that when it comes to backing management teams, we already have an established and meaningful partnership with the business owners. Similarly, with buy and build journeys, we can bring to the table genuine, qualified and transactable opportunities we believe could work in combination with our portfolio businesses. Most recently, I have been involved in the buy and build journey of Bioscript, supporting with the acquisition of two specialist global providers (Fortis Pharma Consulting and Valid Insight), made within 5 months of Sovereign’s investment, and continuously engaging with the management teams of NursePlus and Eden Futures to support their growth ambitions. I am also regularly involved in the identification of new UK tech opportunities to fit alongside our existing portfolio interests, which is an interesting challenge given the extensive market fragmentation and opportunity for consolidation.

Most weekends, I can be found at the nearest clay shooting range. I regularly train in the discipline of Olympic Skeet in which I have represented England twice and most recently, have been selected to represent Great Britain in 2022. However, my aspirations to achieve in this sport are much bigger than that!

Areas of Interest

  • Healthcare & Pharma Services
  • HealthTech & PharmaTech
  • Technology Services
  • Scaling Through Acquisition
  • Succession Planning

Meet More of the Team

Meet all the team